HIV-1 element | Total interactions | Interactions with drug target genes | Corrected p |
---|---|---|---|
Env-gp120 | 856 (22%) | 239 (29%) | 5.85 × 10-6 |
Integrase | 102 (3%) | 5 (1%) | 7.15 × 10-4 |
Rev | 109 (3%) | 7 (1%) | 1.36 × 10-3 |
Env-gp41 | 190 (5%) | 58 (7%) | 4.65 × 10-3 |
Tat | 1394 (35%) | 249 (30%) | 2.50 × 10-2 |
Capsid | 45 (1%) | 16 (2%) | 6.23 × 10-2 |
Vif | 77 (2%) | 8 (1%) | 6.57 × 10-2 |
Nef | 302 (8%) | 78 (10%) | 7.60 × 10-2 |
Pol | 1 (< 1%) | 0 (0%) | 0.238 |
Vpr | 275 (7%) | 47 (6%) | 0.173 |
Env-gp160 | 213 (5%) | 49 (6%) | 0.432 |
Env-gp41 | 190 (5%) | 58 (7%) | 1.07 × 10-2 |
Rev | 109 (3%) | 7 (1%) | 4.50 × 10-3 |
Integrase | 102 (3%) | 5 (1%) | 2.61 × 10-3 |
Matrix | 95 (2%) | 15 (2%) | 0.399 |
Retropepsin | 89 (2%) | 15 (2%) | 0.506 |
Vif | 77 (2%) | 8 (1%) | 0.120 |
Gag | 72 (2%) | 15 (2%) | 0.889 |
Reverse transcriptase | 45 (1%) | 8 (1%) | 0.605 |
Vpu | 27 (1%) | 5 (1%) | 0.667 |
Nucleocapsid | 26 (1%) | 4 (< 1%) | 0.486 |
p6 | 18 (< 1%) | 2 (< 1%) | 0.386 |
p1 | 3 (< 1%) | 0 (0%) | 0.253 |